Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics

In molecular cancer therapeutics only 10% of known cancer gene products are targetable with current pharmacological agents. Major oncogenic drivers, such as MYC and KRAS proteins are frequently highly overexpressed or mutated in multiple human malignancies. However, despite their key role in oncogen...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene
Main Authors: Sorolla, Anabel, Wang, Edina, Golden, Emily, Duffy, Ciara, Henriques, Sónia T., Redfern, Andrew D., Blancafort, Pilar
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2019
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7002299/
https://ncbi.nlm.nih.gov/pubmed/31636382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-1056-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items